Tlc Biopharmaceuticals, Inc.
Clinical trials sponsored by Tlc Biopharmaceuticals, Inc., explained in plain language.
-
New injection could cut opioid use after bunion surgery
Symptom relief Recruiting nowThis study tests a new medicine called TLC590 for pain after bunionectomy (foot bone surgery). About 300 adults will receive either TLC590, a standard painkiller, or a placebo. The goal is to see if TLC590 reduces pain and the need for opioid painkillers in the first 72 hours aft…
Phase: PHASE3 • Sponsor: TLC Biopharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
New shot could keep pain away longer after surgery
Symptom relief Recruiting nowThis study tests TLC590, an extended-release version of the numbing drug ropivacaine, to see how well it controls pain after different surgeries like bunion removal, hernia repair, breast augmentation, tummy tuck, and knee replacement. About 120 adults aged 18 to 70 will receive …
Phase: PHASE2 • Sponsor: TLC Biopharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC